| 6CN8: reference: High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads., Wolf NM, Lee H, Choules MP, Pauli GF, Phansalkar R, Anderson JR, Gao W, Ren J, Santarsiero BD, Lee H, Cheng J, Jin YY, Ho NA, Duc NM, Suh JW, Abad-Zapatero C, Cho S, ACS Infect Dis. 2019 May 3. doi: 10.1021/acsinfecdis.8b00276. PMID: 30990022 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).